Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$172.58 - $196.48 $10.8 Million - $12.3 Million
-62,600 Reduced 32.17%
132,000 $25.8 Million
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $5.4 Million - $6.63 Million
37,100 Added 23.56%
194,600 $33.7 Million
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $10.6 Million - $12.8 Million
64,200 Added 68.81%
157,500 $26.7 Million
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $11.2 Million - $14.8 Million
-74,000 Reduced 44.23%
93,300 $18.4 Million
Q3 2023

Nov 14, 2023

SELL
$167.14 - $192.77 $6.35 Million - $7.33 Million
-38,000 Reduced 18.51%
167,300 $29.1 Million
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $5.67 Million - $6.56 Million
35,200 Added 20.69%
205,300 $35.4 Million
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $712,852 - $857,598
-4,900 Reduced 2.8%
170,100 $28.3 Million
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $603,243 - $724,362
-4,600 Reduced 2.56%
175,000 $25.7 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $18.2 Million - $22.4 Million
-122,600 Reduced 40.57%
179,600 $26.6 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.